Compound information
- Natural Products
- ZC827857
- Molecular Formula
- C14H19NO4
- Molecular Weight
- 265.131408088 g/mol
- Structure
-
- IUPAC Name
- methyl (2S)-2-(benzyloxycarbonylamino)pentanoate
- InChI
- InChI=1S/C14H19NO4/c1-3-7-12(13(16)18-2)15-14(17)19-10-11-8-5-4-6-9-11/h4-6,8-9,12H,3,7,10H2,1-2H3,(H,15,17)/t12-/m0/s1
- InChI Key
- MTVOBSFGSGXXAD-LBPRGKRZSA-N
- SMILES
- CCC[C@H](NC(=O)OCc1ccccc1)C(=O)OC
- Source
- ZINC000034584806
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 64.63 Å2 | LogP | 2.749 |
LogS | -3.07 | LogD | 2.654 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.15 | Pgp substrate | 0.012 |
HIA | 0.968 | F20 % | 0.991 |
F30 % | 0.11 | Caco-2 | -4.578 |
MDCK | -4.583 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.088 | PPB | 83.329 |
VD | 0.876 | Fu | 1.016 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.532 | CYP1A2 substrate | 0.697 |
CYP2A6 substrate | 0.418 | CYP2B6 substrate | 0.557 |
CYP2C19 inhibitor | 0.8 | CYP2C19 substrate | 0.904 |
CYP2C8 substrate | 0.752 | CYP2C9 inhibitor | 0.243 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.75 | CYP2E1 substrate | 0.284 |
CYP3A4 inhibitor | 0.03 | CYP3A4 substrate | 0.868 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.774 | CL | 5.534 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.081 | Hepatotoxicity | 0.862 |
Mutagenicity | 0.029 | Rat Oral Acute Toxicity | 0.006 |
FDAMDD | 0.31 | Skin Sensitization | 0.006 |
Carcinogenicity | 0.014 | Eye Corrosion | 0.009 |
Eye Irritation | 0.053 | Respiratory Toxicity | 0.011 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.592 | IGC50 | 3.201 |
LC50FM | 3.771 | LC50DM | 5.152 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.098 | NR-AR-LBD | 0.178 |
NR-AhR | 0.003 | NR-Aromatase | 0.049 |
NR-ER | 0.23 | NR-ER-LBD | 0.382 |
NR-PPAR-gamma | 0.193 | SR-ARE | 0.032 |
SR-ATAD5 | 0.471 | SR-HSE | 0.128 |
SR-MMP | 0.013 | SR-p53 | 0.032 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.